"Protein","Cluster","Silo","0","3","5","7","9","11","13","15","Avg","StDev","CoeffcientVariance","Variance","Median","Slope","Kurtosis","Skewness","Max","Min","Range","X1st_quartile","X4th_quartile","Sum","Day0.Day15","Day3.Day15","Avg_Day0.7","Avg_Day9.15","X1sthalf.2ndhalf","Range_Day0.7","Range_Day9.15","Sum.TotalProteinIDs","High.Low","Variability","Tag","column1","column2","column3","column4","column5","column6","column7","column8","column9","column10","column11","column12","column13","clean","Entry","Entry.name","Status","Protein.names","Gene.names","Organism","Length","Gene.ontology..biological.process.","Gene.ontology.IDs","Pathway","Cross.reference..UniPathway.","Cross.reference..CDD.","Cross.reference..Pfam.","Gene.ontology..GO."
"CHOYP_AAEL_AAEL008069.2.2|m.60920",16,"3",10,7,12.5,24.5,28,41,30,37,40.7142857143,13.1796844284,"0.3237115474",173.7040816327,37,"#VALUE!","-2.0020304488","0.3400107729",59.5,25,34.5,29,59.5,285,"0.7192982456","1.0438596491",39.625,41.875,-2.25,31.5,32,3.3755774014,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AAEL_AAEL008069.2.2|m.60920","P46531","NOTC1_HUMAN","32.8","625","331","23","1703","2308","306","860","6.00E-68","261","1","P46531","NOTC1_HUMAN","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","NOTCH1 TAN1","Homo sapiens (Human)","2555","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003700; GO:0004857; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006367; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_AAEL_AAEL008069.2.2|m.60920",11,"9",10,10,27.5,21.5,44.5,59.5,48.5,57,40.7142857143,13.1796844284,"0.3237115474",173.7040816327,37,"#VALUE!","-2.0020304488","0.3400107729",59.5,25,34.5,29,59.5,285,"0.7192982456","1.0438596491",39.625,41.875,-2.25,31.5,32,3.3755774014,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AAEL_AAEL008069.2.2|m.60920","P46531","NOTC1_HUMAN","32.8","625","331","23","1703","2308","306","860","6.00E-68","261","1","P46531","NOTC1_HUMAN","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","NOTCH1 TAN1","Homo sapiens (Human)","2555","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003700; GO:0004857; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006367; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_ACT.23.27|m.58454",11,"3",79,47,39,65,32,77,67,54,61.5714285714,37.3787836799,"0.6070800134",1397.1734693878,67,"#VALUE!","1.1217908649","0.2432875424",130,0,130,43.25,130,431,"0.5923076923","0.6153846154",64.125,62.875,1.25,47.5,130,5.1048205614,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.23.27|m.58454","P86700","ACT_CHIOP","45.43","350","33","8","20","369","1","192","1.00E-77","244","1","P86700","ACT_CHIOP","reviewed","Actin, muscle (Alpha-actin) (Fragments)","","Chionoecetes opilio (Crab-beetle)","192","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT.23.27|m.58454",12,"9",79,0,31,69.5,37,80,0,130,61.5714285714,37.3787836799,"0.6070800134",1397.1734693878,67,"#VALUE!","1.1217908649","0.2432875424",130,0,130,43.25,130,431,"0.5923076923","0.6153846154",64.125,62.875,1.25,47.5,130,5.1048205614,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.23.27|m.58454","P86700","ACT_CHIOP","45.43","350","33","8","20","369","1","192","1.00E-77","244","1","P86700","ACT_CHIOP","reviewed","Actin, muscle (Alpha-actin) (Fragments)","","Chionoecetes opilio (Crab-beetle)","192","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT.5.27|m.15585",20,"3",0,189.5,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_ACT.5.27|m.15585",16,"9",0,0,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_ACT.6.27|m.15622",19,"3",0,0,0,86.5,0,0,83,79,36.2142857143,41.9556374067,"1.158538311",1760.2755102041,0,"#VALUE!","-2.7040570179","0.4004934455",91.5,0,91.5,0,91.5,253.5,"0","0",20.75,42.625,-21.875,83,91.5,3.0024872676,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.6.27|m.15622","Q39596","ACT_OXYRB","98.82","85","1","0","3","87","1","85","2.00E-54","177","1","Q39596","ACT_OXYRB","reviewed","Actin (Fragment)","","Oxybasis rubra (Red goosefoot) (Chenopodium rubrum)","85","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT.6.27|m.15622",16,"9",0,0,0,0,0,0,0,91.5,36.2142857143,41.9556374067,"1.158538311",1760.2755102041,0,"#VALUE!","-2.7040570179","0.4004934455",91.5,0,91.5,0,91.5,253.5,"0","0",20.75,42.625,-21.875,83,91.5,3.0024872676,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.6.27|m.15622","Q39596","ACT_OXYRB","98.82","85","1","0","3","87","1","85","2.00E-54","177","1","Q39596","ACT_OXYRB","reviewed","Actin (Fragment)","","Oxybasis rubra (Red goosefoot) (Chenopodium rubrum)","85","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ATPB.1.1|m.21960",8,"3",111,122,113,118.5,123.5,109.5,77.5,63.5,74.5714285714,16.2292253389,"0.21763329",263.387755102,77.5,"#VALUE!","1.2518785766","-0.5082964257",100.5,44,56.5,68.25,100.5,522,"1.3353658537","0.993902439",78.125,79.75,-1.625,65.5,37,6.1826365036,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ATPB.1.1|m.21960","Q25117","ATPB_HEMPU","81.47","491","87","3","5","494","6","493","0","791","1","Q25117","ATPB_HEMPU","reviewed","ATP synthase subunit beta, mitochondrial (EC 3.6.3.14)","","Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)","523","ATP synthesis coupled proton transport [GO:0015986]","GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933","","","","PF00006;PF02874;","mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"
"CHOYP_ATPB.1.1|m.21960",11,"9",111,119,92.5,71,109,81.5,100.5,82,74.5714285714,16.2292253389,"0.21763329",263.387755102,77.5,"#VALUE!","1.2518785766","-0.5082964257",100.5,44,56.5,68.25,100.5,522,"1.3353658537","0.993902439",78.125,79.75,-1.625,65.5,37,6.1826365036,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ATPB.1.1|m.21960","Q25117","ATPB_HEMPU","81.47","491","87","3","5","494","6","493","0","791","1","Q25117","ATPB_HEMPU","reviewed","ATP synthase subunit beta, mitochondrial (EC 3.6.3.14)","","Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)","523","ATP synthesis coupled proton transport [GO:0015986]","GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933","","","","PF00006;PF02874;","mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"
"CHOYP_BRAFLDRAFT_127065.6.7|m.30727",11,"3",93,157.5,90.5,31.5,21.5,18.5,14,20,11.8571428571,4.0241617203,"0.339387133",16.193877551,12,"#VALUE!","1.2235397958","1.0984858489",20,7.5,12.5,8.5,20,83,"2.0555555556","1.3888888889",13.125,12.25,0.875,11,12,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_127065.6.7|m.30727","Q62009","POSTN_MOUSE","34.22","263","163","7","46","302","110","368","3.00E-36","142","1","Q62009","POSTN_MOUSE","reviewed","Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)","Postn Osf2","Mus musculus (Mouse)","838","bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]","GO:0001666; GO:0001953; GO:0003073; GO:0005578; GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523","","","","PF02469;","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; proteinaceous extracellular matrix [GO:0005578]; trans-Golgi network [GO:0005802]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]"
"CHOYP_BRAFLDRAFT_127065.6.7|m.30727",20,"9",93,138.5,33,14,10,12.5,8,9,11.8571428571,4.0241617203,"0.339387133",16.193877551,12,"#VALUE!","1.2235397958","1.0984858489",20,7.5,12.5,8.5,20,83,"2.0555555556","1.3888888889",13.125,12.25,0.875,11,12,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_127065.6.7|m.30727","Q62009","POSTN_MOUSE","34.22","263","163","7","46","302","110","368","3.00E-36","142","1","Q62009","POSTN_MOUSE","reviewed","Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)","Postn Osf2","Mus musculus (Mouse)","838","bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]","GO:0001666; GO:0001953; GO:0003073; GO:0005578; GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523","","","","PF02469;","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; proteinaceous extracellular matrix [GO:0005578]; trans-Golgi network [GO:0005802]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]"
"CHOYP_BRAFLDRAFT_277494.3.3|m.62602",11,"3",41.5,44.5,54.5,53,54.5,50.5,42.5,44.5,40.6428571429,7.9897894023,"0.196585328",63.8367346939,42.5,"#VALUE!","5.0574415926","-2.1425633201",47,22,25,40.75,47,284.5,"1.0744680851","0.8617021277",38.875,44.875,-6,28.5,6,3.3696553358,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_277494.3.3|m.62602","Q80XI3","IF4G3_MOUSE","44.26","1037","501","20","608","1613","589","1579","0","826","1","Q80XI3","IF4G3_MOUSE","reviewed","Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","Eif4g3","Mus musculus (Mouse)","1579","positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]","GO:0001934; GO:0003723; GO:0003743; GO:0007283; GO:0045727; GO:0060903","","","","PF02847;PF02854;PF02020;","RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]"
"CHOYP_BRAFLDRAFT_277494.3.3|m.62602",16,"9",41.5,43,44,34.5,50,40.5,41,47,40.6428571429,7.9897894023,"0.196585328",63.8367346939,42.5,"#VALUE!","5.0574415926","-2.1425633201",47,22,25,40.75,47,284.5,"1.0744680851","0.8617021277",38.875,44.875,-6,28.5,6,3.3696553358,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_277494.3.3|m.62602","Q80XI3","IF4G3_MOUSE","44.26","1037","501","20","608","1613","589","1579","0","826","1","Q80XI3","IF4G3_MOUSE","reviewed","Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","Eif4g3","Mus musculus (Mouse)","1579","positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]","GO:0001934; GO:0003723; GO:0003743; GO:0007283; GO:0045727; GO:0060903","","","","PF02847;PF02854;PF02020;","RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]"
"CHOYP_BRAFLDRAFT_80496.6.10|m.29014",11,"3",19.5,21.5,54,85,58,27,14.5,10.5,15,6.8712652193,"0.458084348",47.2142857143,14.5,"#VALUE!","1.1436296264","0.909633954",28.5,5.5,23,11,28.5,105,"2.347826087","1.7391304348",16.75,16.25,0.5,21.5,18,1.2436337795,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_80496.6.10|m.29014","Q6DFV8","VWDE_MOUSE","29.2","250","153","9","4630","4867","394","631","2.00E-20","103","1","Q6DFV8","VWDE_MOUSE","reviewed","von Willebrand factor D and EGF domain-containing protein","Vwde Gm467","Mus musculus (Mouse)","926","","GO:0005576","","","","PF00094;","extracellular region [GO:0005576]"
"CHOYP_BRAFLDRAFT_80496.6.10|m.29014",16,"9",19.5,21.5,39.5,38,33,20,14.5,11.5,15,6.8712652193,"0.458084348",47.2142857143,14.5,"#VALUE!","1.1436296264","0.909633954",28.5,5.5,23,11,28.5,105,"2.347826087","1.7391304348",16.75,16.25,0.5,21.5,18,1.2436337795,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_80496.6.10|m.29014","Q6DFV8","VWDE_MOUSE","29.2","250","153","9","4630","4867","394","631","2.00E-20","103","1","Q6DFV8","VWDE_MOUSE","reviewed","von Willebrand factor D and EGF domain-containing protein","Vwde Gm467","Mus musculus (Mouse)","926","","GO:0005576","","","","PF00094;","extracellular region [GO:0005576]"
"CHOYP_CNDP2.3.4|m.30467",16,"9",31,37,44,38.5,46,47.5,48,23.5,40.8571428571,9.8114884764,"0.2401413263",96.2653061224,47.5,"#VALUE!","-0.9931708768","-0.8081263084",51,23.5,27.5,33.75,51,286,"2","2.0212765957",40.5,42.75,-2.25,16.5,27.5,3.3874215326,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CNDP2.3.4|m.30467","Q9D1A2","CNDP2_MOUSE","69.98","473","141","1","1","472","1","473","0","713","1","Q9D1A2","CNDP2_MOUSE","reviewed","Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)","Cndp2 Cn2","Mus musculus (Mouse)","475","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0008237; GO:0016805; GO:0046872; GO:0070062; GO:0102008; GO:0103046","","","cd05676;","PF07687;PF01546;","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]"
"CHOYP_CNDP2.3.4|m.30467",11,"3",31,35,20,34.5,39.5,47,36.5,51,40.8571428571,9.8114884764,"0.2401413263",96.2653061224,47.5,"#VALUE!","-0.9931708768","-0.8081263084",51,23.5,27.5,33.75,51,286,"2","2.0212765957",40.5,42.75,-2.25,16.5,27.5,3.3874215326,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CNDP2.3.4|m.30467","Q9D1A2","CNDP2_MOUSE","69.98","473","141","1","1","472","1","473","0","713","1","Q9D1A2","CNDP2_MOUSE","reviewed","Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)","Cndp2 Cn2","Mus musculus (Mouse)","475","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0008237; GO:0016805; GO:0046872; GO:0070062; GO:0102008; GO:0103046","","","cd05676;","PF07687;PF01546;","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]"
"CHOYP_contig_041958|m.48141",16,"3",15,16.5,37.5,41.5,30.5,33.5,21.5,24,31.4285714286,17.5609724988,"0.5587582159",308.387755102,24,"#VALUE!","-0.7649746768","0.6228376789",60.5,7.5,53,21,60.5,220,"0.5537190083","0.5454545455",23.875,39.5,-15.625,26,40,2.6057088713,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_041958|m.48141",11,"9",15,21.5,38,43.5,35.5,33,53,60.5,31.4285714286,17.5609724988,"0.5587582159",308.387755102,24,"#VALUE!","-0.7649746768","0.6228376789",60.5,7.5,53,21,60.5,220,"0.5537190083","0.5454545455",23.875,39.5,-15.625,26,40,2.6057088713,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_DNAH5.2.2|m.61452",11,"3",133,112.5,61,60.5,41.5,24.5,31.5,19,25.9285714286,9.0649583224,"0.3496127177",82.1734693878,24.5,"#VALUE!","-0.5933611499","-0.2516489403",39,10.5,28.5,20.75,39,181.5,"1","1.5918367347",26.375,25.125,1.25,28.5,15.5,2.1497098188,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DNAH5.2.2|m.61452","Q8TE73","DYH5_HUMAN","62.56","4631","1627","21","57","4592","6","4624","0","5986","1","Q8TE73","DYH5_HUMAN","reviewed","Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","DNAH5 DNAHC5 HL1 KIAA1603","Homo sapiens (Human)","4624","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0016887; GO:0021670; GO:0030317; GO:0036157; GO:0036158; GO:0060271","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]"
"CHOYP_DNAH5.2.2|m.61452",16,"9",133,57,45,40.5,15,39,34.5,24.5,25.9285714286,9.0649583224,"0.3496127177",82.1734693878,24.5,"#VALUE!","-0.5933611499","-0.2516489403",39,10.5,28.5,20.75,39,181.5,"1","1.5918367347",26.375,25.125,1.25,28.5,15.5,2.1497098188,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DNAH5.2.2|m.61452","Q8TE73","DYH5_HUMAN","62.56","4631","1627","21","57","4592","6","4624","0","5986","1","Q8TE73","DYH5_HUMAN","reviewed","Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","DNAH5 DNAHC5 HL1 KIAA1603","Homo sapiens (Human)","4624","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0016887; GO:0021670; GO:0030317; GO:0036157; GO:0036158; GO:0060271","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]"
"CHOYP_EF1A.2.4|m.50858",1,"3",268.5,295.5,332,294.5,298,358,294.5,288,286.3571428571,61.6683029752,"0.2153545128",3802.9795918367,294.5,"#VALUE!","2.0096192064","-1.3964052516",349,156.5,192.5,269.25,349,2004.5,"1.0257879656","0.9312320917",283.5,307.125,-23.625,201.5,98.5,23.7415610565,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_EF1A.2.4|m.50858","Q92005","EF1A_DANRE","84.53","459","71","0","1","459","1","459","0","813","1","Q92005","EF1A_DANRE","reviewed","Elongation factor 1-alpha (EF-1-alpha)","eef1a ef1a","Danio rerio (Zebrafish) (Brachydanio rerio)","462","","GO:0003746; GO:0003924; GO:0005525; GO:0005622; GO:0005737","","","","PF03144;PF03143;","cytoplasm [GO:0005737]; intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]"
"CHOYP_EF1A.2.4|m.50858",21,"9",268.5,349,319.5,281.5,356.5,325,341,349,286.3571428571,61.6683029752,"0.2153545128",3802.9795918367,294.5,"#VALUE!","2.0096192064","-1.3964052516",349,156.5,192.5,269.25,349,2004.5,"1.0257879656","0.9312320917",283.5,307.125,-23.625,201.5,98.5,23.7415610565,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_EF1A.2.4|m.50858","Q92005","EF1A_DANRE","84.53","459","71","0","1","459","1","459","0","813","1","Q92005","EF1A_DANRE","reviewed","Elongation factor 1-alpha (EF-1-alpha)","eef1a ef1a","Danio rerio (Zebrafish) (Brachydanio rerio)","462","","GO:0003746; GO:0003924; GO:0005525; GO:0005622; GO:0005737","","","","PF03144;PF03143;","cytoplasm [GO:0005737]; intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]"
"CHOYP_EF2.5.5|m.39855",16,"9",65,46,48,34.5,7.5,8.5,26.5,14,28.0714285714,12.8547616843,"0.4579304417",165.2448979592,26.5,"#VALUE!","-1.7466703255","-0.2523770252",43,8.5,34.5,18.5,43,196.5,"0.5","0.6071428571",19.5,31.375,-11.875,32.5,29,2.3273717873,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39855","A7GZW3","LEPA_CAMC5","42.57","148","69","3","18","165","3","134","8.00E-24","110","1","A7GZW3","LEPA_CAMC5","reviewed","Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)","lepA Ccur92_14510 CCV52592_1454","Campylobacter curvus (strain 525.92)","596","translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005886; GO:0006412","","","","PF00679;PF03144;PF06421;","plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]"
"CHOYP_EF2.5.5|m.39855",11,"3",65,42,61.5,54,35,7,39.5,43,28.0714285714,12.8547616843,"0.4579304417",165.2448979592,26.5,"#VALUE!","-1.7466703255","-0.2523770252",43,8.5,34.5,18.5,43,196.5,"0.5","0.6071428571",19.5,31.375,-11.875,32.5,29,2.3273717873,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39855","A7GZW3","LEPA_CAMC5","42.57","148","69","3","18","165","3","134","8.00E-24","110","1","A7GZW3","LEPA_CAMC5","reviewed","Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)","lepA Ccur92_14510 CCV52592_1454","Campylobacter curvus (strain 525.92)","596","translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005886; GO:0006412","","","","PF00679;PF03144;PF06421;","plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]"
"CHOYP_EF2.5.5|m.39856",11,"3",51,52,49.5,46.5,48,42,37,37,36.5714285714,7.1435713929,"0.1953320303",51.0306122449,38,"#VALUE!","4.9185647214","-2.0654897104",43,20,23,37,43,256,"0.976744186","0.8953488372",34.375,40.125,-5.75,22,6,3.0320975956,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39856","Q7QC84","MMSA_ANOGA","73.94","518","132","1","11","525","4","521","0","808","1","Q7QC84","MMSA_ANOGA","reviewed","Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)","AGAP002499","Anopheles gambiae (African malaria mosquito)","521","","GO:0004491; GO:0005739; GO:0018478","","","cd07085;","PF00171;","mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]"
"CHOYP_EF2.5.5|m.39856",16,"9",51,52,43.5,39.5,43,38.5,42.5,43,36.5714285714,7.1435713929,"0.1953320303",51.0306122449,38,"#VALUE!","4.9185647214","-2.0654897104",43,20,23,37,43,256,"0.976744186","0.8953488372",34.375,40.125,-5.75,22,6,3.0320975956,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39856","Q7QC84","MMSA_ANOGA","73.94","518","132","1","11","525","4","521","0","808","1","Q7QC84","MMSA_ANOGA","reviewed","Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)","AGAP002499","Anopheles gambiae (African malaria mosquito)","521","","GO:0004491; GO:0005739; GO:0018478","","","cd07085;","PF00171;","mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]"
"CHOYP_EIF5A.1.3|m.22684",11,"3",29,52.5,56.5,38.5,37.5,48,26,42,35.1428571429,10.8124078385,"0.3076701417",116.9081632653,39.5,"#VALUE!","0.0931478411","-0.7735797499",49.5,15,34.5,29,49.5,246,"0.9696969697","0.6464646465",30.25,43.25,-13,33,10,2.9136562833,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF5A.1.3|m.22684","P10160","IF5A1_RABIT","64.56","158","51","2","1","158","1","153","3.00E-69","213","1","P10160","IF5A1_RABIT","reviewed","Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D)","EIF5A","Oryctolagus cuniculus (Rabbit)","154","mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]","GO:0003746; GO:0005643; GO:0005789; GO:0006452; GO:0015031; GO:0043022; GO:0045727; GO:0045901; GO:0045905; GO:0051028","","","","PF01287;","endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]"
"CHOYP_EIF5A.1.3|m.22684",16,"9",29,44,37.5,23,41.5,32,42,49.5,35.1428571429,10.8124078385,"0.3076701417",116.9081632653,39.5,"#VALUE!","0.0931478411","-0.7735797499",49.5,15,34.5,29,49.5,246,"0.9696969697","0.6464646465",30.25,43.25,-13,33,10,2.9136562833,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF5A.1.3|m.22684","P10160","IF5A1_RABIT","64.56","158","51","2","1","158","1","153","3.00E-69","213","1","P10160","IF5A1_RABIT","reviewed","Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D)","EIF5A","Oryctolagus cuniculus (Rabbit)","154","mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]","GO:0003746; GO:0005643; GO:0005789; GO:0006452; GO:0015031; GO:0043022; GO:0045727; GO:0045901; GO:0045905; GO:0051028","","","","PF01287;","endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]"
"CHOYP_FLNA.2.6|m.11845",14,"3",2,1,155.5,76.5,4.5,102.5,1.5,3.5,58.5,70.3618200041,"1.2027661539",4950.7857142857,3.5,"#VALUE!","-0.4055242928","0.977525335",190.5,1.5,189,2.25,190.5,409.5,"1.1202185792","1.2896174863",56.125,71.875,-15.75,116.5,188.5,4.8501717399,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNA.2.6|m.11845","Q9VEN1","FLNA_DROME","51.02","2250","1031","24","21","2242","4","2210","0","2251","1","Q9VEN1","FLNA_DROME","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)","2210","behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]","GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
"CHOYP_FLNA.2.6|m.11845",28,"9",2,154.5,3,155.5,86.5,118,190.5,91.5,58.5,70.3618200041,"1.2027661539",4950.7857142857,3.5,"#VALUE!","-0.4055242928","0.977525335",190.5,1.5,189,2.25,190.5,409.5,"1.1202185792","1.2896174863",56.125,71.875,-15.75,116.5,188.5,4.8501717399,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNA.2.6|m.11845","Q9VEN1","FLNA_DROME","51.02","2250","1031","24","21","2242","4","2210","0","2251","1","Q9VEN1","FLNA_DROME","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)","2210","behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]","GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
"CHOYP_FLNC.2.5|m.37450",4,"3",209.5,222,91,171.5,245,80.5,254.5,257.5,195.7857142857,61.7991314912,"0.3156467862",3819.1326530612,223.5,"#VALUE!","-0.5239838356","-0.9221614872",257.5,83.5,174,157.5,257.5,1370.5,"0.3601789709","0.3736017897",150.875,211.875,-61,174,127.5,16.2323818548,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNC.2.5|m.37450","P21333","FLNA_HUMAN","43.8","2413","1251","41","559","2905","273","2646","0","1793","1","P21333","FLNA_HUMAN","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)","FLNA FLN FLN1","Homo sapiens (Human)","2647","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]","GO:0001664; GO:0001948; GO:0002576; GO:0003723; GO:0004871; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030863; GO:0031012; GO:0031267; GO:0031523; GO:0031532; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042789; GO:0042803; GO:0042993; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090307; GO:0097440; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G-protein coupled receptor binding [GO:0001664]; glycoprotein binding [GO:0001948]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; signal transducer activity [GO:0004871]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]"
"CHOYP_FLNC.2.5|m.37450",23,"9",209.5,91,268,88.5,191.5,83.5,130,223.5,195.7857142857,61.7991314912,"0.3156467862",3819.1326530612,223.5,"#VALUE!","-0.5239838356","-0.9221614872",257.5,83.5,174,157.5,257.5,1370.5,"0.3601789709","0.3736017897",150.875,211.875,-61,174,127.5,16.2323818548,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNC.2.5|m.37450","P21333","FLNA_HUMAN","43.8","2413","1251","41","559","2905","273","2646","0","1793","1","P21333","FLNA_HUMAN","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)","FLNA FLN FLN1","Homo sapiens (Human)","2647","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]","GO:0001664; GO:0001948; GO:0002576; GO:0003723; GO:0004871; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030863; GO:0031012; GO:0031267; GO:0031523; GO:0031532; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042789; GO:0042803; GO:0042993; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090307; GO:0097440; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G-protein coupled receptor binding [GO:0001664]; glycoprotein binding [GO:0001948]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; signal transducer activity [GO:0004871]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]"
"CHOYP_GCN1L.1.1|m.1352",11,"3",32,37,52,54.5,53.5,42,28.5,40.5,33.2142857143,8.8715320905,"0.2670998909",78.7040816327,36,"#VALUE!","2.7489850366","-1.578387338",42.5,14,28.5,31.5,42.5,232.5,"1.2173913043","1.231884058",31.75,36.875,-5.125,28.5,6,2.7537605117,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_GCN1L.1.1|m.1352","E9PVA8","GCN1_MOUSE","51.12","2682","1286","16","6","2674","1","2670","0","2597","1","E9PVA8","GCN1_MOUSE","reviewed","eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)","Gcn1 Gcn1l1","Mus musculus (Mouse)","2671","cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]","GO:0003723; GO:0005829; GO:0005844; GO:0005913; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0098641; GO:1990253","","","","","cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]"
"CHOYP_GCN1L.1.1|m.1352",16,"9",32,42.5,44,37,41,42.5,36,34.5,33.2142857143,8.8715320905,"0.2670998909",78.7040816327,36,"#VALUE!","2.7489850366","-1.578387338",42.5,14,28.5,31.5,42.5,232.5,"1.2173913043","1.231884058",31.75,36.875,-5.125,28.5,6,2.7537605117,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_GCN1L.1.1|m.1352","E9PVA8","GCN1_MOUSE","51.12","2682","1286","16","6","2674","1","2670","0","2597","1","E9PVA8","GCN1_MOUSE","reviewed","eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)","Gcn1 Gcn1l1","Mus musculus (Mouse)","2671","cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]","GO:0003723; GO:0005829; GO:0005844; GO:0005913; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0098641; GO:1990253","","","","","cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]"
"CHOYP_HSP7D.2.3|m.34782",11,"3",68.5,78.5,105.5,69,98,113.5,72,93.5,89.5714285714,26.5039465679,"0.2958973301",702.4591836735,93.5,"#VALUE!","-0.9527858627","-0.0520850437",125,47,78,71.5,125,627,"0.908","0.76",81.875,103.25,-21.375,66.5,54,7.4262702831,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP7D.2.3|m.34782","Q9U639","HSP7D_MANSE","89.2","611","62","1","8","618","6","612","0","1136","1","Q9U639","HSP7D_MANSE","reviewed","Heat shock 70 kDa protein cognate 4 (Hsc 70-4)","","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","652","","GO:0005524; GO:0005634","","","","PF00012;","nucleus [GO:0005634]; ATP binding [GO:0005524]"
"CHOYP_HSP7D.2.3|m.34782",8,"9",68.5,86,99,98,113.5,95,123.5,125,89.5714285714,26.5039465679,"0.2958973301",702.4591836735,93.5,"#VALUE!","-0.9527858627","-0.0520850437",125,47,78,71.5,125,627,"0.908","0.76",81.875,103.25,-21.375,66.5,54,7.4262702831,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP7D.2.3|m.34782","Q9U639","HSP7D_MANSE","89.2","611","62","1","8","618","6","612","0","1136","1","Q9U639","HSP7D_MANSE","reviewed","Heat shock 70 kDa protein cognate 4 (Hsc 70-4)","","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","652","","GO:0005524; GO:0005634","","","","PF00012;","nucleus [GO:0005634]; ATP binding [GO:0005524]"
"CHOYP_LOC100372926.2.3|m.61794",11,"3",51,44,50.5,58.5,62.5,48.5,36.5,33,34.7857142857,7.4203250933,"0.2133153004",55.0612244898,35,"#VALUE!","0.8028052793","-0.6917070315",44,20.5,23.5,32,44,243.5,"1.1022727273","0.9886363636",37.25,35.75,1.5,28,13,2.8840459552,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100372926.2.3|m.61794","P48605","TCPG_DROME","69.6","556","154","4","164","716","1","544","0","805","1","P48605","TCPG_DROME","reviewed","T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","Cctgamma CCT-3 Cctg CG8977","Drosophila melanogaster (Fruit fly)","544","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]","GO:0005524; GO:0005832; GO:0005875; GO:0006457; GO:0006458; GO:0007430; GO:0042623; GO:0044183; GO:0051082; GO:0060439; GO:0061077","","","cd03337;","PF00118;","chaperonin-containing T-complex [GO:0005832]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]"
"CHOYP_LOC100372926.2.3|m.61794",16,"9",51,41.5,47,42.5,38.5,43.5,35,44,34.7857142857,7.4203250933,"0.2133153004",55.0612244898,35,"#VALUE!","0.8028052793","-0.6917070315",44,20.5,23.5,32,44,243.5,"1.1022727273","0.9886363636",37.25,35.75,1.5,28,13,2.8840459552,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100372926.2.3|m.61794","P48605","TCPG_DROME","69.6","556","154","4","164","716","1","544","0","805","1","P48605","TCPG_DROME","reviewed","T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","Cctgamma CCT-3 Cctg CG8977","Drosophila melanogaster (Fruit fly)","544","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]","GO:0005524; GO:0005832; GO:0005875; GO:0006457; GO:0006458; GO:0007430; GO:0042623; GO:0044183; GO:0051082; GO:0060439; GO:0061077","","","cd03337;","PF00118;","chaperonin-containing T-complex [GO:0005832]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]"
"CHOYP_LOC100648516.1.1|m.64902",16,"3",11,21,32,44.5,56,34,40.5,23.5,40.2857142857,23.852009713,"0.5920711631",568.9183673469,40.5,"#VALUE!","-0.540092811","0.6438285403",83,13.5,69.5,19,83,282,"0.5483870968","0.7258064516",33.25,45.75,-12.5,31.5,68.5,3.3400450077,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100648516.1.1|m.64902","Q01705","NOTC1_MOUSE","31.32","645","362","19","1723","2313","243","860","2.00E-63","246","1","Q01705","NOTC1_MOUSE","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Notch1 Motch","Mus musculus (Mouse)","2531","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004872; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007219; GO:0007220; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046982; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901189; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_LOC100648516.1.1|m.64902",11,"9",11,28.5,25,32.5,66,45,83,62,40.2857142857,23.852009713,"0.5920711631",568.9183673469,40.5,"#VALUE!","-0.540092811","0.6438285403",83,13.5,69.5,19,83,282,"0.5483870968","0.7258064516",33.25,45.75,-12.5,31.5,68.5,3.3400450077,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100648516.1.1|m.64902","Q01705","NOTC1_MOUSE","31.32","645","362","19","1723","2313","243","860","2.00E-63","246","1","Q01705","NOTC1_MOUSE","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Notch1 Motch","Mus musculus (Mouse)","2531","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004872; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007219; GO:0007220; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046982; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901189; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_LOC100699383.1.1|m.63490",11,"9",24,31,35.5,22.5,69,61,28,43,32.6428571429,13.8530921915,"0.4243835682",191.9081632653,28,"#VALUE!","1.430531119","1.2774372006",61,18.5,42.5,23.5,61,228.5,"1.488372093","1.4186046512",40.625,32.5,8.125,45.5,15,2.7063839867,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100699383.1.1|m.63490","Q95VY2","TCTP_BRABE","51.15","174","80","3","1","174","1","169","5.00E-55","177","1","Q95VY2","TCTP_BRABE","reviewed","Translationally-controlled tumor protein homolog (TCTP)","","Branchiostoma belcheri (Amphioxus)","169","","GO:0005737","","","","PF00838;","cytoplasm [GO:0005737]"
"CHOYP_LOC100699383.1.1|m.63490",16,"3",24,27.5,35,29,38.5,64,19,28,32.6428571429,13.8530921915,"0.4243835682",191.9081632653,28,"#VALUE!","1.430531119","1.2774372006",61,18.5,42.5,23.5,61,228.5,"1.488372093","1.4186046512",40.625,32.5,8.125,45.5,15,2.7063839867,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100699383.1.1|m.63490","Q95VY2","TCTP_BRABE","51.15","174","80","3","1","174","1","169","5.00E-55","177","1","Q95VY2","TCTP_BRABE","reviewed","Translationally-controlled tumor protein homolog (TCTP)","","Branchiostoma belcheri (Amphioxus)","169","","GO:0005737","","","","PF00838;","cytoplasm [GO:0005737]"
"CHOYP_LOC100890099.1.1|m.11505",18,"3",85,0,0,0,102,0,0,87.5,38.9285714286,39.7361193837,"1.0207443511",1578.9591836735,26.5,"#VALUE!","-1.9248213056","0.4617119756",98.5,0,98.5,0,98.5,272.5,"#DIV/0!","#DIV/0!",31.25,36.875,-5.625,98.5,87.5,3.227525761,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100890099.1.1|m.11505","P53486","ACTB3_TAKRU","82.86","280","10","1","1","280","119","360","2.00E-164","468","1","P53486","ACTB3_TAKRU","reviewed","Actin, cytoplasmic 3 (Beta-actin C) [Cleaved into: Actin, cytoplasmic 3, N-terminally processed]","actbc","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","375","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC100890099.1.1|m.11505",16,"9",85,0,21,47,0,98.5,0,0,38.9285714286,39.7361193837,"1.0207443511",1578.9591836735,26.5,"#VALUE!","-1.9248213056","0.4617119756",98.5,0,98.5,0,98.5,272.5,"#DIV/0!","#DIV/0!",31.25,36.875,-5.625,98.5,87.5,3.227525761,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100890099.1.1|m.11505","P53486","ACTB3_TAKRU","82.86","280","10","1","1","280","119","360","2.00E-164","468","1","P53486","ACTB3_TAKRU","reviewed","Actin, cytoplasmic 3 (Beta-actin C) [Cleaved into: Actin, cytoplasmic 3, N-terminally processed]","actbc","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","375","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC101169658.2.3|m.20752",12,"3",1,2.5,17.5,54,60.5,100,76,131,112.0714285714,36.2525157466,"0.3234768773",1314.2448979592,127,"#VALUE!","0.4654627285","-1.0651752661",157,42.5,114.5,97.25,157,784.5,"0.7874015748","0.9330708661",84.25,136.875,-52.625,76,30,9.2917209523,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC101169658.2.3|m.20752",27,"9",1,10.5,38,76.5,105.5,118.5,157,127,112.0714285714,36.2525157466,"0.3234768773",1314.2448979592,127,"#VALUE!","0.4654627285","-1.0651752661",157,42.5,114.5,97.25,157,784.5,"0.7874015748","0.9330708661",84.25,136.875,-52.625,76,30,9.2917209523,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC752782.1.1|m.53937",17,"3",0,104,177,0,0,0,0,0,15.5714285714,35.946814454,"2.30851102",1292.1734693878,0,"#VALUE!","6.9366293238","2.6306492786",103.5,0,103.5,0,103.5,109,"#DIV/0!","#DIV/0!",0,27.25,-27.25,0,103.5,1.2910103044,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC752782.1.1|m.53937","O17320","ACT_CRAGI","99.2","376","3","0","58","433","1","376","0","783","1","O17320","ACT_CRAGI","reviewed","Actin","","Crassostrea gigas (Pacific oyster) (Crassostrea angulata)","376","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC752782.1.1|m.53937",30,"9",0,219,117.5,0,73.5,0,103.5,0,15.5714285714,35.946814454,"2.30851102",1292.1734693878,0,"#VALUE!","6.9366293238","2.6306492786",103.5,0,103.5,0,103.5,109,"#DIV/0!","#DIV/0!",0,27.25,-27.25,0,103.5,1.2910103044,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC752782.1.1|m.53937","O17320","ACT_CRAGI","99.2","376","3","0","58","433","1","376","0","783","1","O17320","ACT_CRAGI","reviewed","Actin","","Crassostrea gigas (Pacific oyster) (Crassostrea angulata)","376","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC754102.1.1|m.57578",11,"9",92,69.5,42.5,28,33.5,58,42,43,23.5714285714,21.8246724267,"0.9258951939",476.3163265306,12.5,"#VALUE!","-1.8721621069","0.4286446657",58,0,58,4.75,58,165,"0.5813953488","1.3488372093",23.125,24.375,-1.25,58,43,1.9542816534,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC754102.1.1|m.57578","P02553","TBA_LYTPI","97.84","139","3","0","1","139","23","161","6.00E-97","283","1","P02553","TBA_LYTPI","reviewed","Tubulin alpha chain (Fragment)","","Lytechinus pictus (Painted sea urchin)","161","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_LOC754102.1.1|m.57578",16,"3",92,25.5,25.5,51,20.5,25,9.5,0,23.5714285714,21.8246724267,"0.9258951939",476.3163265306,12.5,"#VALUE!","-1.8721621069","0.4286446657",58,0,58,4.75,58,165,"0.5813953488","1.3488372093",23.125,24.375,-1.25,58,43,1.9542816534,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC754102.1.1|m.57578","P02553","TBA_LYTPI","97.84","139","3","0","1","139","23","161","6.00E-97","283","1","P02553","TBA_LYTPI","reviewed","Tubulin alpha chain (Fragment)","","Lytechinus pictus (Painted sea urchin)","161","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_LRP5.1.3|m.18025",16,"3",44,46.5,53,41,35,35,36.5,38.5,43.0714285714,15.9652045118,"0.3706680981",254.887755102,38.5,"#VALUE!","0.6954929265","0.7247621461",73.5,20.5,53,33.75,73.5,301.5,"0.6481481481","0.8796296296",34.875,49.25,-14.375,27,42.5,3.5710055667,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LRP5.1.3|m.18025","Q24JV9","L3BPA_DANRE","48.21","112","54","3","146","257","34","141","1.00E-23","110","1","Q24JV9","L3BPA_DANRE","reviewed","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","lgals3bpa lgals3bp zgc:136780","Danio rerio (Zebrafish) (Brachydanio rerio)","567","cell adhesion [GO:0007155]","GO:0005044; GO:0005578; GO:0007155; GO:0016020","","","","PF07707;PF00651;PF00530;","membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]"
"CHOYP_LRP5.1.3|m.18025",11,"9",44,60,51,52,47,47.5,73.5,54,43.0714285714,15.9652045118,"0.3706680981",254.887755102,38.5,"#VALUE!","0.6954929265","0.7247621461",73.5,20.5,53,33.75,73.5,301.5,"0.6481481481","0.8796296296",34.875,49.25,-14.375,27,42.5,3.5710055667,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LRP5.1.3|m.18025","Q24JV9","L3BPA_DANRE","48.21","112","54","3","146","257","34","141","1.00E-23","110","1","Q24JV9","L3BPA_DANRE","reviewed","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","lgals3bpa lgals3bp zgc:136780","Danio rerio (Zebrafish) (Brachydanio rerio)","567","cell adhesion [GO:0007155]","GO:0005044; GO:0005578; GO:0007155; GO:0016020","","","","PF07707;PF00651;PF00530;","membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]"
"CHOYP_MATN1.3.5|m.46206",8,"3",71.5,84,139,154,176.5,164.5,140,168.5,160.7142857143,25.3530177731,"0.1577521106",642.7755102041,175.5,"#VALUE!","1.9405942741","-1.6380276549",180.5,107,73.5,154.25,180.5,1125,"0.9373219373","1.0056980057",147,175.375,-28.375,69.5,12,13.3246476371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MATN1.3.5|m.46206","A6NMZ7","CO6A6_HUMAN","29.61","385","248","11","27","409","436","799","1.00E-40","171","1","A6NMZ7","CO6A6_HUMAN","reviewed","Collagen alpha-6(VI) chain","COL6A6","Homo sapiens (Human)","2263","cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]"
"CHOYP_MATN1.3.5|m.46206",3,"9",71.5,120,155.5,154.5,182.5,176.5,180.5,175.5,160.7142857143,25.3530177731,"0.1577521106",642.7755102041,175.5,"#VALUE!","1.9405942741","-1.6380276549",180.5,107,73.5,154.25,180.5,1125,"0.9373219373","1.0056980057",147,175.375,-28.375,69.5,12,13.3246476371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MATN1.3.5|m.46206","A6NMZ7","CO6A6_HUMAN","29.61","385","248","11","27","409","436","799","1.00E-40","171","1","A6NMZ7","CO6A6_HUMAN","reviewed","Collagen alpha-6(VI) chain","COL6A6","Homo sapiens (Human)","2263","cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]"
"CHOYP_MBCDH18.1.1|m.34344",9,"3",273.5,247.5,202.5,203,157.5,74,124,88,75.6428571429,32.1044214642,"0.4244210581",1030.693877551,88,"#VALUE!","-0.9571961976","-0.2019291516",124,24,100,51,124,529.5,"3.0833333333","2.2291666667",75,75.875,-0.875,75.5,75,6.2714674879,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MBCDH18.1.1|m.34344","Q2PZL6","FAT4_MOUSE","27.01","3717","2418","143","796","4407","81","3607","0","733","1","Q2PZL6","FAT4_MOUSE","reviewed","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Fat4 Fatj","Mus musculus (Mouse)","4981","branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307","","","","PF00028;PF00008;PF07645;PF12661;PF02210;","apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]"
"CHOYP_MBCDH18.1.1|m.34344",25,"9",273.5,189,170.5,143,58.5,53.5,92.5,24,75.6428571429,32.1044214642,"0.4244210581",1030.693877551,88,"#VALUE!","-0.9571961976","-0.2019291516",124,24,100,51,124,529.5,"3.0833333333","2.2291666667",75,75.875,-0.875,75.5,75,6.2714674879,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MBCDH18.1.1|m.34344","Q2PZL6","FAT4_MOUSE","27.01","3717","2418","143","796","4407","81","3607","0","733","1","Q2PZL6","FAT4_MOUSE","reviewed","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Fat4 Fatj","Mus musculus (Mouse)","4981","branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307","","","","PF00028;PF00008;PF07645;PF12661;PF02210;","apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]"
"CHOYP_MYS.4.7|m.18188",1,"3",254,302.5,310,288,275.5,293.5,243.5,223.5,260.7142857143,95.3178356653,"0.3656026573",9085.4897959184,243.5,"#VALUE!","-1.7088840478","-0.2017672773",379,115.5,263.5,191.75,379,1825,"0.8164116829","0.9568845619",260.25,269.375,-9.125,184,263.5,21.6155395002,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.4.7|m.18188","P24733","MYS_ARGIR","76.84","1926","438","2","7","1932","3","1920","0","2991","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.4.7|m.18188",21,"9",254,318,298.5,259.5,325,344,379,359.5,260.7142857143,95.3178356653,"0.3656026573",9085.4897959184,243.5,"#VALUE!","-1.7088840478","-0.2017672773",379,115.5,263.5,191.75,379,1825,"0.8164116829","0.9568845619",260.25,269.375,-9.125,184,263.5,21.6155395002,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.4.7|m.18188","P24733","MYS_ARGIR","76.84","1926","438","2","7","1932","3","1920","0","2991","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44341",7,"3",168.5,202,143.5,135.5,122,119.5,123.5,91,109.1428571429,46.3709532587,"0.424864755",2150.2653061225,123.5,"#VALUE!","-1.1259115821","-0.262043998",177.5,38.5,139,72.75,177.5,764,"0.8356643357","0.951048951",108.375,112.5,-4.125,81.5,139,9.048916262,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYS.7.7|m.44341","P24733","MYS_ARGIR","79.13","939","189","4","4","938","3","938","0","1541","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44341",8,"9",168.5,155,121,107.5,130,136,177.5,143,109.1428571429,46.3709532587,"0.424864755",2150.2653061225,123.5,"#VALUE!","-1.1259115821","-0.262043998",177.5,38.5,139,72.75,177.5,764,"0.8356643357","0.951048951",108.375,112.5,-4.125,81.5,139,9.048916262,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYS.7.7|m.44341","P24733","MYS_ARGIR","79.13","939","189","4","4","938","3","938","0","1541","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44342",7,"3",195.5,216,145,137,143.5,168.5,144.5,114,139.0714285714,50.757426319,"0.3649737897",2576.3163265306,144.5,"#VALUE!","-1.5302474214","-0.4379117841",193.5,56.5,137,100.75,193.5,973.5,"0.8938992042","1.0026525199",147.375,138.125,9.25,101.5,137,11.5302617553,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.7.7|m.44342","Q8T305","MYSP_TAESA","37.25","851","529","2","150","995","4","854","2.00E-153","483","1","Q8T305","MYSP_TAESA","reviewed","Paramyosin","PMY","Taenia saginata (Beef tapeworm) (Cysticercus bovis)","863","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44342",3,"9",195.5,172.5,147,146.5,199.5,189,193.5,188.5,139.0714285714,50.757426319,"0.3649737897",2576.3163265306,144.5,"#VALUE!","-1.5302474214","-0.4379117841",193.5,56.5,137,100.75,193.5,973.5,"0.8938992042","1.0026525199",147.375,138.125,9.25,101.5,137,11.5302617553,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.7.7|m.44342","Q8T305","MYSP_TAESA","37.25","851","529","2","150","995","4","854","2.00E-153","483","1","Q8T305","MYSP_TAESA","reviewed","Paramyosin","PMY","Taenia saginata (Beef tapeworm) (Cysticercus bovis)","863","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYSP.1.9|m.1097",16,"3",86,19.5,11.5,43.5,23,54.5,23.5,18.5,48.6428571429,38.6095050156,"0.7937343175",1490.693877551,32,"#VALUE!","2.4170707471","1.7292691233",132,18.5,113.5,24.25,132,340.5,"2.18","3.1",46.875,51.875,-5,54,113.5,4.0329266848,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.1.9|m.1097",31,"9",86,21.5,52,9,80.5,77.5,132,25,48.6428571429,38.6095050156,"0.7937343175",1490.693877551,32,"#VALUE!","2.4170707471","1.7292691233",132,18.5,113.5,24.25,132,340.5,"2.18","3.1",46.875,51.875,-5,54,113.5,4.0329266848,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.4.9|m.2302",7,"3",45.5,156,180,135.5,145.5,76,134.5,123,100.8571428571,41.8190953357,"0.4146369226",1748.8367346939,109.5,"#VALUE!","-0.6185966052","-0.3826552884",161.5,30.5,131,73.5,161.5,706,"0.4705882353","0.5448916409",82.25,113.25,-31,104,102.5,8.3619566505,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.4.9|m.2302",26,"9",45.5,198.5,90,175.5,72.5,88,109.5,161.5,100.8571428571,41.8190953357,"0.4146369226",1748.8367346939,109.5,"#VALUE!","-0.6185966052","-0.3826552884",161.5,30.5,131,73.5,161.5,706,"0.4705882353","0.5448916409",82.25,113.25,-31,104,102.5,8.3619566505,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.8.9|m.44813",10,"9",102,69.5,139,125.5,117,101,0,131.5,95.5,40.9912882731,"0.4292281495",1680.2857142857,113.5,"#VALUE!","4.9760019405","-2.1443020688",131.5,0,131.5,94.75,131.5,668.5,"0.7604562738","0.7680608365",108.75,83.375,25.375,20,131.5,7.9178017292,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYSP.8.9|m.44813","O96064","MYSP_MYTGA","79.36","688","142","0","12","699","177","864","0","998","1","O96064","MYSP_MYTGA","reviewed","Paramyosin","","Mytilus galloprovincialis (Mediterranean mussel)","864","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYSP.8.9|m.44813",8,"3",102,133.5,125.5,130.5,127.5,100,114,113.5,95.5,40.9912882731,"0.4292281495",1680.2857142857,113.5,"#VALUE!","4.9760019405","-2.1443020688",131.5,0,131.5,94.75,131.5,668.5,"0.7604562738","0.7680608365",108.75,83.375,25.375,20,131.5,7.9178017292,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYSP.8.9|m.44813","O96064","MYSP_MYTGA","79.36","688","142","0","12","699","177","864","0","998","1","O96064","MYSP_MYTGA","reviewed","Paramyosin","","Mytilus galloprovincialis (Mediterranean mussel)","864","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_ODO1.2.2|m.23540",11,"3",46,44,52.5,48,45,40,33.5,34,32.8571428571,7.42925821,"0.2261078586",55.193877551,34,"#VALUE!","5.1541274187","-2.1385656096",39.5,15.5,24,33.5,39.5,230,"1.038961039","0.8701298701",30.625,36.875,-6.25,24.5,5.5,2.7241501836,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ODO1.2.2|m.23540","Q60HE2","ODO1_MACFA","59.24","1023","368","12","4","1000","20","1019","0","1216","1","Q60HE2","ODO1_MACFA","reviewed","2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)","OGDH QccE-15394","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","1023","generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966; GO:0046872","","","","PF16078;PF00676;PF16870;PF02779;","mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]"
"CHOYP_ODO1.2.2|m.23540",16,"9",46,45.5,46,42.5,44.5,33.5,39.5,38.5,32.8571428571,7.42925821,"0.2261078586",55.193877551,34,"#VALUE!","5.1541274187","-2.1385656096",39.5,15.5,24,33.5,39.5,230,"1.038961039","0.8701298701",30.625,36.875,-6.25,24.5,5.5,2.7241501836,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ODO1.2.2|m.23540","Q60HE2","ODO1_MACFA","59.24","1023","368","12","4","1000","20","1019","0","1216","1","Q60HE2","ODO1_MACFA","reviewed","2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)","OGDH QccE-15394","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","1023","generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966; GO:0046872","","","","PF16078;PF00676;PF16870;PF02779;","mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]"
"CHOYP_PAN2.1.1|m.44691",15,"3",80,113.5,0,103,0,60,0,0,47.7857142857,76.3655948817,"1.5980841978",5831.7040816327,0,"#VALUE!","-0.2832277982","1.3192503216",188,0,188,0,188,334.5,"0.409556314","1.2832764505",62,36.625,25.375,188,146.5,3.9618618974,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PAN2.1.1|m.44691","Q25381","ACTM_LYTPI","71.3","108","30","1","13","120","27","133","1.00E-46","159","1","Q25381","ACTM_LYTPI","reviewed","Actin, muscle (LPM) (Fragment)","","Lytechinus pictus (Painted sea urchin)","172","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_PAN2.1.1|m.44691",29,"9",80,93,0,0,60,188,0,146.5,47.7857142857,76.3655948817,"1.5980841978",5831.7040816327,0,"#VALUE!","-0.2832277982","1.3192503216",188,0,188,0,188,334.5,"0.409556314","1.2832764505",62,36.625,25.375,188,146.5,3.9618618974,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PAN2.1.1|m.44691","Q25381","ACTM_LYTPI","71.3","108","30","1","13","120","27","133","1.00E-46","159","1","Q25381","ACTM_LYTPI","reviewed","Actin, muscle (LPM) (Fragment)","","Lytechinus pictus (Painted sea urchin)","172","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_PHUM_PHUM226120.2.7|m.2274",13,"3",23,13.5,20,35,19.5,21.5,200.5,104.5,73.9285714286,57.8331519925,"0.7822841815",3344.6734693878,52,"#VALUE!","2.9304625829","1.6851505326",200.5,22,178.5,35.25,200.5,517.5,"0.8958333333","2.1666666667",85.5,49.25,36.25,179,82.5,6.1293379131,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.2.7|m.2274","Q8WZ42","TITIN_HUMAN","31.58","2486","1574","57","1398","3814","18470","20897","0","1040","1","Q8WZ42","TITIN_HUMAN","reviewed","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","TTN","Homo sapiens (Human)","34350","cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]"
"CHOYP_PHUM_PHUM226120.2.7|m.2274",16,"9",23,22.5,25.5,34,24.5,52,22,24,73.9285714286,57.8331519925,"0.7822841815",3344.6734693878,52,"#VALUE!","2.9304625829","1.6851505326",200.5,22,178.5,35.25,200.5,517.5,"0.8958333333","2.1666666667",85.5,49.25,36.25,179,82.5,6.1293379131,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.2.7|m.2274","Q8WZ42","TITIN_HUMAN","31.58","2486","1574","57","1398","3814","18470","20897","0","1040","1","Q8WZ42","TITIN_HUMAN","reviewed","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","TTN","Homo sapiens (Human)","34350","cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]"
"CHOYP_PHUM_PHUM226120.7.7|m.54053",22,"9",179,258,244.5,201.5,276,278,307,299.5,196.2142857143,94.3378643656,"0.4807899895",8899.6326530612,188,"#VALUE!","-1.4704064806","-0.2701887653",307,42.5,264.5,129.25,307,1373.5,"0.8196994992","0.9282136895",173.5,231.25,-57.75,235.5,176.5,16.2679142485,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.7.7|m.54053","Q23551","UNC22_CAEEL","42.4","3344","1854","37","1383","4699","3842","7140","0","2639","1","Q23551","UNC22_CAEEL","reviewed","Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)","unc-22 ZK617.1","Caenorhabditis elegans","7158","adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]","GO:0004674; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0046872; GO:0051782; GO:0060298","","","cd00063;","PF00041;PF07679;PF00069;","A band [GO:0031672]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]"
"CHOYP_PHUM_PHUM226120.7.7|m.54053",2,"3",179,250,251,239.5,215,245.5,42.5,130.5,196.2142857143,94.3378643656,"0.4807899895",8899.6326530612,188,"#VALUE!","-1.4704064806","-0.2701887653",307,42.5,264.5,129.25,307,1373.5,"0.8196994992","0.9282136895",173.5,231.25,-57.75,235.5,176.5,16.2679142485,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.7.7|m.54053","Q23551","UNC22_CAEEL","42.4","3344","1854","37","1383","4699","3842","7140","0","2639","1","Q23551","UNC22_CAEEL","reviewed","Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)","unc-22 ZK617.1","Caenorhabditis elegans","7158","adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]","GO:0004674; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0046872; GO:0051782; GO:0060298","","","cd00063;","PF00041;PF07679;PF00069;","A band [GO:0031672]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]"
"CHOYP_SMP_012720.2.2|m.34968",16,"3",34,37.5,37,39,41.5,43,41.5,47,42.7142857143,8.472042859,"0.1983421405",71.7755102041,43,"#VALUE!","0.6332015041","-0.5358296889",55.5,27,28.5,39,55.5,299,"0.7747747748","0.8738738739",40,45.5,-5.5,21.5,19,3.5413952387,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMP_012720.2.2|m.34968","Q9WUM3","COR1B_MOUSE","50.3","501","225","9","1","495","1","483","1.00E-175","510","1","Q9WUM3","COR1B_MOUSE","reviewed","Coronin-1B (Coronin-2)","Coro1b","Mus musculus (Mouse)","484","actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]","GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005913; GO:0005925; GO:0015629; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:0098641; GO:1902463; GO:2000394","","","","PF08953;PF00400;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]"
"CHOYP_SMP_012720.2.2|m.34968",11,"9",34,37,18,38.5,42,48.5,43,55.5,42.7142857143,8.472042859,"0.1983421405",71.7755102041,43,"#VALUE!","0.6332015041","-0.5358296889",55.5,27,28.5,39,55.5,299,"0.7747747748","0.8738738739",40,45.5,-5.5,21.5,19,3.5413952387,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMP_012720.2.2|m.34968","Q9WUM3","COR1B_MOUSE","50.3","501","225","9","1","495","1","483","1.00E-175","510","1","Q9WUM3","COR1B_MOUSE","reviewed","Coronin-1B (Coronin-2)","Coro1b","Mus musculus (Mouse)","484","actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]","GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005913; GO:0005925; GO:0015629; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:0098641; GO:1902463; GO:2000394","","","","PF08953;PF00400;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]"
"CHOYP_SPTCA.1.2|m.1905",10,"3",56.5,59.5,146.5,148,138.5,150,0,142,100.7857142857,71.472700654,"0.7091550738",5108.3469387755,142,"#VALUE!","-1.9046886253","-0.5988734731",174,0,174,33.75,174,705.5,"0.9118541033","0.9574468085",76.875,137,-60.125,157.5,106.5,8.3560345849,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_SPTCA.1.2|m.1905","P02549","SPTA1_HUMAN","46.96","2453","1249","13","2","2443","8","2419","0","2138","1","P02549","SPTA1_HUMAN","reviewed","Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)","SPTA1 SPTA","Homo sapiens (Human)","2419","actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]","GO:0000165; GO:0002260; GO:0005088; GO:0005200; GO:0005509; GO:0005829; GO:0006779; GO:0006888; GO:0007009; GO:0007015; GO:0007411; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030097; GO:0030424; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0051015; GO:0051693","","","","PF08726;PF00018;PF00435;","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]"
"CHOYP_SPTCA.1.2|m.1905",8,"9",56.5,125.5,128.5,125,164.5,157.5,174,164.5,100.7857142857,71.472700654,"0.7091550738",5108.3469387755,142,"#VALUE!","-1.9046886253","-0.5988734731",174,0,174,33.75,174,705.5,"0.9118541033","0.9574468085",76.875,137,-60.125,157.5,106.5,8.3560345849,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_SPTCA.1.2|m.1905","P02549","SPTA1_HUMAN","46.96","2453","1249","13","2","2443","8","2419","0","2138","1","P02549","SPTA1_HUMAN","reviewed","Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)","SPTA1 SPTA","Homo sapiens (Human)","2419","actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]","GO:0000165; GO:0002260; GO:0005088; GO:0005200; GO:0005509; GO:0005829; GO:0006779; GO:0006888; GO:0007009; GO:0007015; GO:0007411; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030097; GO:0030424; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0051015; GO:0051693","","","","PF08726;PF00018;PF00435;","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]"
"CHOYP_SPTCA.2.2|m.25615",13,"3",50.5,74.5,6.5,5,11,10.5,133,75,57.0714285714,45.2985560882,"0.7937168776",2051.9591836735,75,"#VALUE!","-1.2907646454","0.2772764034",133,7.5,125.5,9.5,133,399.5,"1.05","0.75",58.375,44.125,14.25,125.5,73.5,4.7317304276,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SPTCA.2.2|m.25615","P13395","SPTCA_DROME","68.87","2432","736","5","1","2428","1","2415","0","3439","1","P13395","SPTCA_DROME","reviewed","Spectrin alpha chain","alpha-Spec SPEC-A CG1977","Drosophila melanogaster (Fruit fly)","2415","actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","GO:0003779; GO:0005509; GO:0005794; GO:0005811; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007293; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008091; GO:0008092; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693; GO:0060429","","","cd00051;","PF13499;PF08726;PF00018;PF00435;","basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lipid particle [GO:0005811]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]"
"CHOYP_SPTCA.2.2|m.25615",16,"9",50.5,67.5,11,10,77,7.5,9,10,57.0714285714,45.2985560882,"0.7937168776",2051.9591836735,75,"#VALUE!","-1.2907646454","0.2772764034",133,7.5,125.5,9.5,133,399.5,"1.05","0.75",58.375,44.125,14.25,125.5,73.5,4.7317304276,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SPTCA.2.2|m.25615","P13395","SPTCA_DROME","68.87","2432","736","5","1","2428","1","2415","0","3439","1","P13395","SPTCA_DROME","reviewed","Spectrin alpha chain","alpha-Spec SPEC-A CG1977","Drosophila melanogaster (Fruit fly)","2415","actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","GO:0003779; GO:0005509; GO:0005794; GO:0005811; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007293; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008091; GO:0008092; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693; GO:0060429","","","cd00051;","PF13499;PF08726;PF00018;PF00435;","basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lipid particle [GO:0005811]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]"
"CHOYP_TAGL3.1.1|m.31031",16,"3",41,44.5,42.5,35,39.5,47,30,35,44.4285714286,16.2841477943,"0.3665242269",265.1734693878,36.5,"#VALUE!","-2.2146762365","0.1198037602",64,22,42,32.5,64,311,"0.7899159664","1.0756302521",40.75,48.75,-8,42,29,3.6835248135,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TAGL3.1.1|m.31031","P37805","TAGL3_RAT","32.7","159","94","6","6","162","4","151","6.00E-11","61.6","1","P37805","TAGL3_RAT","reviewed","Transgelin-3 (Neuronal protein 22) (NP22) (Neuronal protein NP25)","Tagln3 Np25","Rattus norvegicus (Rat)","199","","","","","cd00014;","PF00402;PF00307;",""
"CHOYP_TAGL3.1.1|m.31031",11,"9",41,47,38.5,32,51.5,64,64,59.5,44.4285714286,16.2841477943,"0.3665242269",265.1734693878,36.5,"#VALUE!","-2.2146762365","0.1198037602",64,22,42,32.5,64,311,"0.7899159664","1.0756302521",40.75,48.75,-8,42,29,3.6835248135,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TAGL3.1.1|m.31031","P37805","TAGL3_RAT","32.7","159","94","6","6","162","4","151","6.00E-11","61.6","1","P37805","TAGL3_RAT","reviewed","Transgelin-3 (Neuronal protein 22) (NP22) (Neuronal protein NP25)","Tagln3 Np25","Rattus norvegicus (Rat)","199","","","","","cd00014;","PF00402;PF00307;",""
"CHOYP_TBB4B.1.7|m.12262",6,"3",114.5,136.5,222.5,227.5,171,114,129.5,62.5,141,74.3072770903,"0.5270019652",5521.5714285714,129.5,"#VALUE!","-2.5217133606","0.0783226146",227.5,52,175.5,68.75,227.5,987,"0.5277777778","1.0532407407",136.5,138.75,-2.25,152.5,172.5,11.6901575269,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_TBB4B.1.7|m.12262","Q07972","TBAA_PNECA","39.15","212","121","1","202","405","1","212","9.00E-53","182","1","Q07972","TBAA_PNECA","reviewed","Tubulin alpha chain (Fragment)","TUB-A","Pneumocystis carinii","212","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBB4B.1.7|m.12262",24,"9",114.5,223,95,119.5,150,227.5,224.5,216,141,74.3072770903,"0.5270019652",5521.5714285714,129.5,"#VALUE!","-2.5217133606","0.0783226146",227.5,52,175.5,68.75,227.5,987,"0.5277777778","1.0532407407",136.5,138.75,-2.25,152.5,172.5,11.6901575269,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_TBB4B.1.7|m.12262","Q07972","TBAA_PNECA","39.15","212","121","1","202","405","1","212","9.00E-53","182","1","Q07972","TBAA_PNECA","reviewed","Tubulin alpha chain (Fragment)","TUB-A","Pneumocystis carinii","212","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBB4B.7.7|m.63980",5,"3",372.5,301.5,169.5,165,146,239,157.5,211,137.5,55.8358563751,"0.4060789555",3117.6428571429,130.5,"#VALUE!","0.1890949114","-0.4573167201",211,35,176,113,211,962.5,"2.0340425532","0.9234042553",135,165.375,-30.375,204,93.5,11.3999763117,"high_abundance","high_variance","high_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TBB4B.7.7|m.63980",7,"9",372.5,174,221.5,146,183,108.5,130.5,117.5,137.5,55.8358563751,"0.4060789555",3117.6428571429,130.5,"#VALUE!","0.1890949114","-0.4573167201",211,35,176,113,211,962.5,"2.0340425532","0.9234042553",135,165.375,-30.375,204,93.5,11.3999763117,"high_abundance","high_variance","high_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TCPD.1.1|m.13556",11,"3",38,41.5,39.5,37.5,66.5,39.5,31,35,31.3571428571,6.7066826253,"0.2138805393",44.9795918367,32.5,"#VALUE!","4.4159141851","-1.9668229204",37.5,16,21.5,31,37.5,219.5,"1.0821917808","1.0273972603",31,33.75,-2.75,23.5,5.5,2.5997868056,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TCPD.1.1|m.13556","Q2T9X2","TCPD_BOVIN","77.03","518","117","2","16","532","24","540","0","827","1","Q2T9X2","TCPD_BOVIN","reviewed","T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","CCT4","Bos taurus (Bovine)","542","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006458; GO:0042470; GO:0044183; GO:0051082; GO:0061077","","","cd03338;","PF00118;","chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]"
"CHOYP_TCPD.1.1|m.13556",16,"9",38,38,38.5,33,36.5,37.5,32.5,36.5,31.3571428571,6.7066826253,"0.2138805393",44.9795918367,32.5,"#VALUE!","4.4159141851","-1.9668229204",37.5,16,21.5,31,37.5,219.5,"1.0821917808","1.0273972603",31,33.75,-2.75,23.5,5.5,2.5997868056,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TCPD.1.1|m.13556","Q2T9X2","TCPD_BOVIN","77.03","518","117","2","16","532","24","540","0","827","1","Q2T9X2","TCPD_BOVIN","reviewed","T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","CCT4","Bos taurus (Bovine)","542","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006458; GO:0042470; GO:0044183; GO:0051082; GO:0061077","","","cd03338;","PF00118;","chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]"
"CHOYP_VOLCADRAFT_93060.2.2|m.26741",11,"3",110.5,102,50,40,43.5,44.5,27,28.5,29.2142857143,5.6748640189,"0.1942496241",32.2040816327,28.5,"#VALUE!","0.8466458963","-0.1776749979",38.5,19,19.5,27,38.5,204.5,"1.6481481481","1.2592592593",31.125,31.125,0,25.5,11.5,2.4221248371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_VOLCADRAFT_93060.2.2|m.26741","P81262","IPSG_UNCUN","36.27","102","46","4","55","138","22","122","7.00E-10","58.2","1","P81262","IPSG_PANUN","reviewed","Double-headed protease inhibitor, submandibular gland","","Panthera uncia (Snow leopard) (Uncia uncia)","122","","GO:0004867; GO:0005576","","","","PF00050;","extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]"
"CHOYP_VOLCADRAFT_93060.2.2|m.26741",16,"9",110.5,54,32,26.5,33.5,34,30.5,27,29.2142857143,5.6748640189,"0.1942496241",32.2040816327,28.5,"#VALUE!","0.8466458963","-0.1776749979",38.5,19,19.5,27,38.5,204.5,"1.6481481481","1.2592592593",31.125,31.125,0,25.5,11.5,2.4221248371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_VOLCADRAFT_93060.2.2|m.26741","P81262","IPSG_UNCUN","36.27","102","46","4","55","138","22","122","7.00E-10","58.2","1","P81262","IPSG_PANUN","reviewed","Double-headed protease inhibitor, submandibular gland","","Panthera uncia (Snow leopard) (Uncia uncia)","122","","GO:0004867; GO:0005576","","","","PF00050;","extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]"
